Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial

Feier Song, Guoli Sun, Jin Liu, Ji-Yan Chen, Yibo He, Liwei Liu, Yong Liu, RESCIND group, Feier Song, Guoli Sun, Jin Liu, Ji-Yan Chen, Yibo He, Liwei Liu, Yong Liu, RESCIND group

Abstract

Background: Contrast-induced acute kidney injury (CI-AKI) contributes toward unfavorable clinical outcomes. Oral hydration with water is inexpensive and it may be effective in the prevention of CI-AKI, but its efficacy among patients undergoing primary percutaneous coronary intervention (PCI) remains unknown.

Methods/design: Our study is a secondary analysis on the database from the ATTEMPT study. We enrolled ST-elevation myocardial infarction (STEMI) patients undergoing primary PCI. Eligible patients received peri-procedural aggressive (left ventricular end-diastolic pressure-guided) or routine (≤ 500 mL) intravenous hydration with an isotonic solution (0.9% NaCl) with randomization. The primary endpoint was CI-AKI, defined as a > 25% or 0.5 mg/dL increase in serum creatinine from baseline during the first 48-72 h post-procedurally. All patients drank unrestricted amounts of fluids freely, the volume of which was recorded until 24 h following primary PCI. Oral hydration volume/weight (OHV/W) ratios were calculated. The association between post-procedural oral hydration (quartiles) and CI-AKI was assessed using multivariable analysis controlling for confounders, including intravenous hydration strategies.

Discussion: Our study determined the effects of post-procedural oral hydration on CI-AKI following primary PCI, which is a potential strategy for CI-AKI prevention among patients with STEMI at very high risk.

Trial registration: ClinicalTrials.gov, NCT02067195 . Registered on 21 February 2014.

Keywords: Contrast media; Contrast-induced acute kidney injury; Oral hydration; Primary percutaneous coronary intervention; ST-elevation myocardial infarction.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The schedule of enrolment, interventions, and assessments. CI-AKI contrast-induced acute kidney injury

References

    1. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108(22):2769–2775. doi: 10.1161/01.CIR.0000103623.63687.21.
    1. Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35(23):1533–1540. doi: 10.1093/eurheartj/ehu063.
    1. Singri N, Ahya SN, Levin ML. Acute renal failure. JAMA. 2003;289(6):747–751. doi: 10.1001/jama.289.6.747.
    1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103(5):368–375. doi: 10.1016/S0002-9343(97)00150-2.
    1. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113(14):1799–1806. doi: 10.1161/CIRCULATIONAHA.105.595090.
    1. James MT, Ghali WA, Knudtson ML, et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation. 2011;123(4):409–416. doi: 10.1161/CIRCULATIONAHA.110.970160.
    1. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004;44(7):1343–1353.
    1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275(19):1489–1494. doi: 10.1001/jama.1996.03530430033035.
    1. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44(9):1780–1785. doi: 10.1016/j.jacc.2004.07.043.
    1. Pyxaras SA, Sinagra G, Mangiacapra F, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am J Cardiol. 2013;111(5):684–688. doi: 10.1016/j.amjcard.2012.11.018.
    1. Neumann Franz-Josef,Sousa-Uva Miguel,Ahlsson Anders et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. [J] Eur. Heart J. 2019;40:87-165.
    1. Akyuz S, Karaca M, Kemaloglu OT, et al. Efficacy of oral hydration in the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention. Nephron Clin Pract. 2014;128(1–2):95–100. doi: 10.1159/000365090.
    1. Agarwal SK, Mohareb S, Patel A, et al. Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data. Open Heart. 2015;2(1):e000317. doi: 10.1136/openhrt-2015-000317.
    1. Liu Y, Chen JY, Huo Y, et al. Aggressive hydration in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention to prevent contrast-induced nephropathy (ATTEMPT): study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (first study for reduction of contrast-induced nephropathy following cardiac catheterization) trial. Am Heart J. 2016;172:88–95. doi: 10.1016/j.ahj.2015.10.007.
    1. Briguori C, Visconti G, Rivera NV, et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010;121(19):2117–2122. doi: 10.1161/CIRCULATIONAHA.109.919639.
    1. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399.
    1. Tan N, Liu Y, Chen JY, et al. Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention. Am Heart J. 2013;165(4):600–608. doi: 10.1016/j.ahj.2012.12.017.
    1. Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med. 2009;151(9):631–638. doi: 10.7326/0003-4819-151-9-200911030-00008.
    1. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):491–498. doi: 10.1161/CIRCINTERVENTIONS.110.955310.
    1. Oduncu V, Erkol A, Karabay CY, et al. Relation of the severity of contrast induced nephropathy to SYNTAX score and long-term prognosis in patients treated with primary percutaneous coronary intervention. Int J Cardiol. 2013;168(4):3480–3485. doi: 10.1016/j.ijcard.2013.04.166.
    1. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest. 1998;114(6):1570–1574. doi: 10.1378/chest.114.6.1570.
    1. Garcia-Ruiz C, Martinez-Vea A, Sempere T, et al. Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydratation. Clin Nephrol. 2004;61(3):170–176. doi: 10.5414/CNP61170.
    1. Yoshikawa D, Isobe S, Sato K, et al. Importance of oral fluid intake after coronary computed tomography angiography: an observational study. Eur J Radiol. 2011;77(1):118–122. doi: 10.1016/j.ejrad.2009.07.011.
    1. Wrobel W, Sinkiewicz W, Gordon M, Wozniak-Wisniewska A. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol. 2010;68(9):1015–1020.
    1. Cho R, Javed N, Traub D, et al. Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. J Interv Cardiol. 2010;23(5):460–466. doi: 10.1111/j.1540-8183.2010.00585.x.
    1. Kong DG, Hou YF, Ma LL, Yao DK, Wang LX. Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial. Acta Cardiol. 2012;67(5):565–569. doi: 10.1080/AC.67.5.2174131.
    1. Cheungpasitporn W, Thongprayoon C, Brabec BA, et al. Oral hydration for prevention of contrast-induced acute kidney injury in elective radiological procedures: a systematic review and meta-analysis of randomized controlled trials. N Am J Med Sci. 2014;6(12):618–624. doi: 10.4103/1947-2714.147977.
    1. Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One. 2013;8(3):e60009. doi: 10.1371/journal.pone.0060009.
    1. Zhang Weidai, Zhang Jiawei, Yang Baojun, Wu Kefei, Lin Hanfei, Wang Yanping, Zhou Lihong, Wang Huatao, Zeng Chujuan, Chen Xiao, Wang Zhixing, Zhu Junxing, Songming Chen. Effectiveness of oral hydration in preventing contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention. Coronary Artery Disease. 2018;29(4):286–293. doi: 10.1097/MCA.0000000000000607.
    1. Angoulvant Denis, Cucherat Michel, Rioufol Gilles, Finet Gérard, Beaune Jacques, Revel Didier, Laville Maurice, Ovize Michel, André-Fouët Xavier. Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial. Archives of Cardiovascular Diseases. 2009;102(11):761–767. doi: 10.1016/j.acvd.2009.07.001.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅